Practice-updates
Global Journal of Reproductive Medicine:
Endometriosis is a common disease in up to 10% of women of reproductive
age. It often causes symptoms such as dysmenorrhea, chronic pelvic pain,
dyspareunia and dyschezia. It is also associated with ovarian endometrioma
which requires surgery for both diagnosis and treatment. However, recurrence
r...
Threatened miscarriage is the most common complication in the
first half of pregnancy affecting 20-25% of women. Diagnosis of threatened
miscarriage is established when there is a viable pregnancy with vaginal
bleeding and a closed cervix.
Any woman who presents with threatened miscarriage;
ultrasound imaging is performed to ascertain th...
ADA Diabetes Care Journal:
Metformin
is the recommended first-line pharmacotherapy for patients with type 2 diabetes,
but most patients will ultimately require additional therapies to maintain
glycemic control.
Maintaining
intensive glucose control early in the disease process may lead to legacy
benefits that persist beyond the per...
PubMed Central: Published: July, 2021
Urticaria is a frequent, mast cell–driven disease that
presents with wheals, angioedema, or both. The lifetime prevalence for acute
urticaria is approximately 20%.
Chronic idiopathic urticaria (CIU) is a common skin condition
characterized by the appearance of recurrent wheals and/or angioede...
Treatment guidelines for type 2
diabetes mellitus (T2DM) recommend initiating pharmacotherapy with an oral
antidiabetic drug (OAD) to reduce hyperglycaemia when diet and exercise are
inadequate.
International guidelines recommend
metformin as the first OAD, whereas Japanese guidelines recognize that other
OADs may be more appropriate i...
The management of gastroesophageal
reflux disease (GERD) has been revolutionized with the development of proton
pump inhibitors (PPIs). Unfortunately, due to the inherent pharmacokinetic and
pharmacodynamic profiles of conventional PPIs, many patients continue to suffer
from symptoms related to GERD despite appropriate use of PPIs.
Curr...
JAMA: The Journal of the American Medical Association: Published
on April 5, 2022
Epilepsy affects approximately 65
million people worldwide. Persistent seizures are associated with a 20% to 40%
risk of bodily injuries (eg, fractures, burns, concussions) over 12-month
follow-up. The primary goal of epilepsy treatment is to eliminate seiz...
American Diabetes Association (ADA)
Professional Practice Committee: Recommendations
Treatment Strategies
Lifestyle Intervention:
Recommendation
For patients with blood pressure
>120/80 mmHg, lifestyle intervention consists of weight loss when
indicated, a Dietary Approaches to Stop Hypertension (DASH)-style eating
pattern inclu...
Diabetes Care: American Diabetes Association Journal
The standard pharmacotherapy for
management of type 2 diabetes mellitus (T2DM) involves initiation with
monotherapy (usually metformin) unless there are contraindications or
intolerance, followed by sequential addition of other single agents, when
target glycaemic control is not achieved o...
The New England Journal
of Medicine (NEJM): Published
on July 15, 2021
The incidence rate of a single unprovoked seizure among
adults is 23 to 61 cases per 100,000 person-years.
After a first unprovoked seizure, the overall risk of
recurrence may be as high as 60%, and this risk is highest within the first 2
years.
Epilepsy is...
American Journal of Dermatology and Venereology: Published: Feb. 26, 2021
Dermatophytic infections are the
most common fungal infections affecting 20%–25% population globally. The hot
and humid climate in the tropical and subtropical countries like Bangladesh
makes Dermatophytosis is very common fungal infection.
Terbinafine is considered...
The American Diabetes Association
(ADA) “Standards of Medical Care in Diabetes” includes the ADA’s current
clinical practice recommendations and is intended to provide the components of
diabetes care, general treatment goals and guidelines, and tools to evaluate
quality of care.
Atherosclerotic cardiovascular
disease (ASCVD)—defined as...
